James H. Reamer

Array ( [id] => 4004070 [patent_doc_number] => 05859065 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Treatment method for cancer' [patent_app_type] => 1 [patent_app_number] => 8/904958 [patent_app_country] => US [patent_app_date] => 1997-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 6591 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859065.pdf [firstpage_image] =>[orig_patent_app_number] => 904958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575314 [patent_doc_number] => 06469035 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid' [patent_app_type] => B1 [patent_app_number] => 08/903755 [patent_app_country] => US [patent_app_date] => 1997-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18754 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469035.pdf [firstpage_image] =>[orig_patent_app_number] => 08903755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3762133 [patent_doc_number] => 05852020 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Nefazodone: use in treating post traumatic stress disorder' [patent_app_type] => 1 [patent_app_number] => 8/904011 [patent_app_country] => US [patent_app_date] => 1997-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1687 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852020.pdf [firstpage_image] =>[orig_patent_app_number] => 904011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3779178 [patent_doc_number] => 05817881 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Tetraalykylammonium polyoxoanionic oxidation catalysts' [patent_app_type] => 1 [patent_app_number] => 8/902931 [patent_app_country] => US [patent_app_date] => 1997-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3220 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817881.pdf [firstpage_image] =>[orig_patent_app_number] => 902931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3955930 [patent_doc_number] => 05935946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Nucleotide analog composition and synthesis method' [patent_app_type] => 1 [patent_app_number] => 8/900752 [patent_app_country] => US [patent_app_date] => 1997-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10551 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935946.pdf [firstpage_image] =>[orig_patent_app_number] => 900752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3889725 [patent_doc_number] => 05777170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Process for the preparation of a naphthylbutanone' [patent_app_type] => 1 [patent_app_number] => 8/900224 [patent_app_country] => US [patent_app_date] => 1997-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1120 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/777/05777170.pdf [firstpage_image] =>[orig_patent_app_number] => 900224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4074761 [patent_doc_number] => 05965567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Method for treating nicotine addiction' [patent_app_type] => 1 [patent_app_number] => 8/892853 [patent_app_country] => US [patent_app_date] => 1997-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7266 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965567.pdf [firstpage_image] =>[orig_patent_app_number] => 892853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3794005 [patent_doc_number] => 05780505 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones' [patent_app_type] => 1 [patent_app_number] => 8/889166 [patent_app_country] => US [patent_app_date] => 1997-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29926 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 363 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780505.pdf [firstpage_image] =>[orig_patent_app_number] => 889166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4206696 [patent_doc_number] => 06077870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders' [patent_app_type] => 1 [patent_app_number] => 8/888320 [patent_app_country] => US [patent_app_date] => 1997-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6955 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077870.pdf [firstpage_image] =>[orig_patent_app_number] => 888320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089667 [patent_doc_number] => 06133270 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Isothiazolones and pharmaceutical formulations' [patent_app_type] => 1 [patent_app_number] => 8/882846 [patent_app_country] => US [patent_app_date] => 1997-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16324 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 308 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133270.pdf [firstpage_image] =>[orig_patent_app_number] => 882846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046995 [patent_doc_number] => 05912345 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Process for the preparation of lamotrigine' [patent_app_type] => 1 [patent_app_number] => 8/836153 [patent_app_country] => US [patent_app_date] => 1997-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7329 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912345.pdf [firstpage_image] =>[orig_patent_app_number] => 836153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811985 [patent_doc_number] => 05811585 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Process for preparing 5-chloro-2,3-dihydro-1H-inden-1-one' [patent_app_type] => 1 [patent_app_number] => 8/860344 [patent_app_country] => US [patent_app_date] => 1997-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4502 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811585.pdf [firstpage_image] =>[orig_patent_app_number] => 860344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3906630 [patent_doc_number] => 05898032 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-27 [patent_title] => 'Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy' [patent_app_type] => 1 [patent_app_number] => 8/880419 [patent_app_country] => US [patent_app_date] => 1997-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2811 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/898/05898032.pdf [firstpage_image] =>[orig_patent_app_number] => 880419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535264 [patent_doc_number] => 06337071 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Mosquito and/or flea control' [patent_app_type] => B1 [patent_app_number] => 08/878835 [patent_app_country] => US [patent_app_date] => 1997-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 3002 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337071.pdf [firstpage_image] =>[orig_patent_app_number] => 08878835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044183 [patent_doc_number] => 05874461 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Use of Nebivolol as an anti-atherogenic' [patent_app_type] => 1 [patent_app_number] => 8/860238 [patent_app_country] => US [patent_app_date] => 1997-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7329 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874461.pdf [firstpage_image] =>[orig_patent_app_number] => 860238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3783730 [patent_doc_number] => 05821265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Inhibitors of cell-mediated disorders' [patent_app_type] => 1 [patent_app_number] => 8/872901 [patent_app_country] => US [patent_app_date] => 1997-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8786 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821265.pdf [firstpage_image] =>[orig_patent_app_number] => 872901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4133919 [patent_doc_number] => 06015574 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Lipophilic carrier systems' [patent_app_type] => 1 [patent_app_number] => 8/871524 [patent_app_country] => US [patent_app_date] => 1997-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6945 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015574.pdf [firstpage_image] =>[orig_patent_app_number] => 871524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3927879 [patent_doc_number] => 05877183 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists' [patent_app_type] => 1 [patent_app_number] => 8/864885 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 7610 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877183.pdf [firstpage_image] =>[orig_patent_app_number] => 864885 [rel_patent_id] =>[rel_patent_doc_number] =>)